Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/00000441-196312000-00002 | DOI Listing |
Cureus
May 2024
Internal Medicine, Mayo Clinic, Jacksonville, USA.
Chylothorax is a rare condition that results from thoracic duct disruption with malignant and nonmalignant etiologies manifesting as a pleural effusion. Typically, chylothorax in the setting of cirrhosis is associated with the migration of chylous ascites. We present the case of a 64-year-old male with prior liver transplant who presented with new-onset transudative chylothorax without chylous ascites who responded to transjugular intrahepatic portosystemic shunt revision, diuresis, and serial thoracentesis.
View Article and Find Full Text PDFFront Cardiovasc Med
May 2024
Department of Pediatrics, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei Province, China.
Background: Neonatal (enteroviral) myocarditis (NM/NEM) is rare but unpredictable and devastating, with high mortality and morbidity. We report a case of neonatal coxsackievirus B (CVB) fulminant myocarditis successfully treated with veno-arterial extracorporeal membrane oxygenation (V-A ECMO).
Case Presentation: A previously healthy 7-day-old boy presented with fever for 4 days.
Vox Sang
August 2024
Department of Pulmonary and Critical Care Medicine, Jefferson Abington Hospital, Abington, Pennsylvania, USA.
Background And Objectives: Transfusion-related acute lung injury is an infrequent adverse reaction observed in patients receiving blood products. The lung injury can range in severity and can be associated with both mortality and mortality. All blood products except albumin have been linked to cases of transfusion-related acute lung injury.
View Article and Find Full Text PDFKardiol Pol
April 2024
Institute of Heart Diseases, Wroclaw Medical University, Wrocław, Poland.
J Clin Med
January 2024
Department of Internal Medicine III, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Most episodes of acute heart failure (AHF) are characterized by increasing signs and symptoms of congestion, manifested by edema, pleura effusion and/or ascites. Immediately and repeatedly administered intravenous (IV) loop diuretics currently represent the mainstay of initial therapy aiming to achieve adequate diuresis/natriuresis and euvolemia. Despite these efforts, a significant proportion of patients have residual congestion at discharge, which is associated with a poor prognosis.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!